| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f4dce064add4f464596348bea6de4c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a16bc32f55683128983f223de242942 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3873
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6512
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5532 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6512
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-576 |
| filingDate |
1993-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20d18efb04aae47d71046577f4694c4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a47b41e7a1ef8c8c1c026dbcfbfa22e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5e164eeed90ddb80124b2776da4effd |
| publicationDate |
1996-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-94046137-A |
| titleOfInvention |
Phosphonosulfonate compounds for treatment anomal calcium and phosphate metabolism, pharmaceutical composition |
| abstract |
The invention relates to phosphonosulphonates and their therapeutically acceptable salts and esters having the formula I described in the description. The invention relates to pharmaceutical compositions comprising a safe and effective amount of a compound of the invention and pharmaceutically acceptable excipients. The invention relates to methods for treating or preventing pathological conditions characterized by abnormal calcium and phosphate metabolism in humans or mammals, including treating or preventing osteoporosis and arthritis, especially rheumatoid arthritis and osteoarthritis. This method comprises administering to a human or mammal in need of such treatment a safe and effective amount of a compound or composition of the invention. |
| priorityDate |
1992-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |